CHE Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
673.3M
+2.4%
657.5M
+2.8%
639.3M
+2.3%
624.9M
+1.0%
618.8M
Cost of Revenue
451.8M
+2.3%
441.7M
+6.7%
414.2M
-3.2%
428.0M
-1.4%
434.1M
Gross Profit
221.5M
+2.6%
215.8M
-4.2%
225.2M
+14.4%
196.9M
+6.6%
184.7M
Operating Expenses
132.3M
+0.8%
131.2M
+5.4%
124.5M
+1.9%
122.2M
+4.8%
116.6M
R&D
0
0
0
0
0
SG&A
115.2M
+0.8%
114.3M
+8.4%
105.5M
-0.3%
105.8M
+5.4%
100.3M
Operating Income
89.2M
+5.5%
84.6M
-16.0%
100.7M
+34.7%
74.8M
+9.8%
68.1M
EBITDA
106.2M
+4.7%
101.5M
-13.3%
117.0M
+28.6%
91.0M
+7.9%
84.3M
Net Income
67.7M
+2.1%
66.3M
-13.6%
76.8M
+19.5%
64.2M
+22.4%
52.5M
EPS (Basic)
$5.14
+6.0%
$4.85
-11.7%
$5.49
+23.1%
$4.46
+23.9%
$3.60
EPS (Diluted)
$5.13
+6.0%
$4.84
-12.0%
$5.50
+23.3%
$4.46
+24.9%
$3.57
Shares (Diluted)
13.2M
-3.6%
13.7M
-2.0%
14.0M
-3.1%
14.4M
-2.0%
14.7M
Chemed (CHE) โ€” Financials